Roles of periostin in respiratory disorders

American Journal of Respiratory and Critical Care Medicine

Volumn 193, Issue 9, 2016, Pages 949-956

  Izuhara, Kenji ^a   Conway, Simon J ^b   Moore, Bethany B ^c   Matsumoto, Hisako ^d   Holweg, Cecile T J ^e   Matthews, John G ^e   Arron, Joseph R ^e  

^a SAGA UNIVERSITY   (Japan)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d KYOTO UNIVERSITY   (Japan)

^e GENENTECH INC   (United States)

Author keywords

Airway remodeling; Asthma; Biomarker; Idiopathic pulmonary fibrosis; Periostin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; BLEOMYCIN; CORTICOSTEROID; INTERLEUKIN 13; INTERLEUKIN 4; LEBRIKIZUMAB; MONOCLONAL ANTIBODY; OMALIZUMAB; PLACEBO; TRALOKINUMAB; TRANSCRIPTION FACTOR RUNX2; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN;

AIRWAY; AIRWAY REMODELING; ALLERGIC ASTHMA; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; BIOLOGICAL THERAPY; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; BRONCHUS MUCOSA; CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHILIA; EPITHELIUM CELL; FIBROSING ALVEOLITIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LOWER RESPIRATORY TRACT; LUNG FUNCTION; MUCUS SECRETION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SERUM; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT; UPREGULATION; LUNG EPITHELIUM; MULTICENTER STUDY (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); BREATHING DISORDER; GENETICS;

CELL ADHESION MOLECULES; HUMANS; RESPIRATION DISORDERS;

EID: 84963824779     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201510-2032PP     Document Type: Review

References (69)

1. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999;14: 1239-1249.
2. Liu AY, Zheng H, Ouyang G. Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol 2014;37: 150-156.
3. Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, McKenzie AN, Nagai H, Hotokebuchi T, Izuhara K. Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 2006;118: 98-104.
4. Yuyama N, Davies DE, Akaiwa M, Matsui K, Hamasaki Y, Suminami Y, Yoshida NL, Maeda M, Pandit A, Lordan JL, et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine 2002;19: 287-296.
5. Morra L, Rechsteiner M, Casagrande S, von Teichman A, Schraml P, Moch H, Soltermann A. Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer 2012;76: 183-190.
6. Conway SJ, Izuhara K, Kudo Y, Litvin J, Markwald R, Ouyang G, Arron JR, Holweg CT, Kudo A. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci 2014;71: 1279-1288.
7. Snider P, Standley KN, Wang J, Azhar M, Doetschman T, Conway SJ. Origin of cardiac fibroblasts and the role of periostin. Circ Res 2009;105: 934-947.
8. Ahlfeld SK, Gao Y, Wang J, Horgusluoglu E, Bolanis E, Clapp DW, Conway SJ. Periostin downregulation is an early marker of inhibited neonatal murine lung alveolar septation. Birth Defects Res A Clin Mol Teratol 2013;97: 373-385.
9. Bozyk PD, Bentley JK, Popova AP, Anyanwu AC, Linn MD, Goldsmith AM, Pryhuber GS, Moore BB, Hershenson MB. Neonatal periostin knockout mice are protected from hyperoxia-induced alveolar simplication. Plos One 2012;7: E31336.
10. Lopez-Guisa JM, Powers C, File D, Cochrane E, Jimenez N, Debley JS. Airway epithelial cells from asthmatic children differentially express proremodeling factors. J Allergy Clin Immunol 2012;129: 990-7.e6.
11. Akram KM, Samad S, Spiteri MA, Forsyth NR. Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms. Respir Res 2013;14: 9.
12. Hong L, Sun H, Lv X, Yang D, Zhang J, Shi Y. Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro. Mol Biol Rep 2010;37: 2285-2293.
13. Wang M, Wang X, Zhang N, Wang H, Li Y, Fan E, Zhang L, Zhang L, Bachert C. Association of periostin expression with eosinophilic inflammation in nasal polyps. J Allergy Clin Immunol 2015;136: 1700-1703.e9.
14. Ishida A, Ohta N, Suzuki Y, Kakehata S, Okubo K, Ikeda H, Shiraishi H, Izuhara K. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int 2012;61: 589-595.
15. Kim MA, Izuhara K, Ohta S, Ono J, Yoon MK, Ban GY, Yoo HS, Shin YS, Ye YM, Nahm DH, et al. Association of serum periostin with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2014;113: 314-320.
16. Chetta A, Zanini A, Foresi A, D'Ippolito R, Tipa A, Castagnaro A, Baraldo S, Neri M, Saetta M, Olivieri D. Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy 2005;35: 1437-1442.
17. Li W, Gao P, Zhi Y, Xu W, Wu Y, Yin J, Zhang J. Periostin: Its role in asthma and its potential as a diagnostic or therapeutic target. Respir Res 2015;16: 57.
18. Johansson MW, Annis DS, Mosher DF. a(M)b(2) integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin. Am J Respir Cell Mol Biol 2013;48: 503-510.
19. Sherrill JD, Kc K, Wu D, Djukic Z, Caldwell JM, Stucke EM, Kemme KA, Costello MS, Mingler MK, Blanchard C, et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol 2014;7: 718-729.
20. Uchida M, Shiraishi H, Ohta S, Arima K, Taniguchi K, Suzuki S, Okamoto M, Ahlfeld SK, Ohshima K, Kato S, et al. Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol 2012;46: 677-686.
21. Sidhu SS, Yuan S, Innes AL, Kerr S, Woodruff PG, Hou L, Muller SJ, Fahy JV. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci USA 2010;107: 14170-14175.
22. Hackett TL. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Curr Opin Allergy Clin Immunol 2012;12: 53-59.
23. Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, Lenburg ME, Spira A, Woodruff PG. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015;191: 758-766.
24. Blanchard C, Mingler MK, McBride M, Putnam PE, Collins MH, Chang G, Stringer K, Abonia JP, Molkentin JD, Rothenberg ME. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol 2008;1: 289-296.
25. Gordon ED, Sidhu SS, Wang ZE, Woodruff PG, Yuan S, Solon MC, Conway SJ, Huang X, Locksley RM, Fahy JV. A protective role for periostin and TGF-b in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy 2012;42: 144-155.
26. Sehra S, Yao W, Nguyen ET, Ahyi AN, Tuana FM, Ahlfeld SK, Snider P, Tepper RS, Petrache I, Conway SJ, et al. Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation. J Immunol 2011;186: 4959-4966.
27. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick TP, Pantoja C, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 2007;104: 15858-15863.
28. Corren J. Asthma phenotypes and endotypes: An evolving paradigm for classification. Discov Med 2013;15: 243-249.
29. Kim MA, Shin YS, Pham D, Park HS. Adult asthma biomarkers. Curr Opin Allergy Clin Immunol 2014;14: 49-54.
30. Fahy JV. Type 2 inflammation in asthma: Present in most, absent in many. Nat Rev Immunol 2015;15: 57-65.
31. Gibeon D, Menzies-Gow AN. Targeting interleukins to treat severe asthma. Expert Rev Respir Med 2012;6: 423-439.
32. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, Koth LL, Arron JR, Fahy JV. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit CareMed 2009;180: 388-395.
33. Kanemitsu Y, Ito I, Niimi A, Izuhara K, Ohta S, Ono J, Iwata T, Matsumoto H, Mishima M. Osteopontin and periostin are associated with a 20-year decline of pulmonary function in patients with asthma. Am J Respir Crit Care Med 2014;190: 472-474.
34. Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, Pandis I, Bansal AT, Bel EH, Auffray C, et al.; U-BIOPRED Study Group. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J 2015;46: 1308-1321.
35. Matsusaka M, Kabata H, Fukunaga K, Suzuki Y, Masaki K, Mochimaru T, Sakamaki F, Oyamada Y, Inoue T, Oguma T, et al. Phenotype of asthma related with high serum periostin levels. Allergol Int 2015;64: 175-180.
36. Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, et al.; Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroidrefractory Asthma (BOBCAT) Study Group. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012;130: 647-654.e10.
37. Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, Sterk PJ. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax 2015;70: 115-120.
38. Bentley JK, Chen Q, Hong JY, Popova AP, Lei J, Moore BB, Hershenson MB. J Allergy Clin Immunol 2014;134: 1433-1442.
39. Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Kawayama T, Fujimoto K, Ohshima K, Shiraishi H, Uchida M, Ono J, et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 2011;37: 1119-1127.
40. Naik PK, Bozyk PD, Bentley JK, Popova AP, Birch CM, Wilke CA, Fry CD, White ES, Sisson TH, Tayob N, et al.; COMET Investigators. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2012;303: L1046-L1056.
41. Chandriani S, DePianto DJ, N'Diaye EN, Abbas AR, Jackman J, Bevers J III, Ramirez-Carrozzi V, Pappu R, Kauder SE, Toy K, et al. Endogenously expressed IL-13Ra2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts. J Immunol 2014;193: 111-119.
42. Leppäranta O, Sens C, Salmenkivi K, Kinnula VL, Keski-Oja J, Myllärniemi M, Koli K. Regulation of TGF-b storage and activation in the human idiopathic pulmonary fibrosis lung. Cell Tissue Res 2012; 348: 491-503.
43. Nance T, Smith KS, Anaya V, Richardson R, Ho L, Pala M, Mostafavi S, Battle A, Feghali-Bostwick C, Rosen G, et al. Transcriptome analysis reveals differential splicing events in IPF lung tissue. Plos One 2014; 9: E97550.
44. Maruhashi T, Kii I, Saito M, Kudo A. Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem 2010;285: 13294-13303.
45. Ultsch M, Bevers J, Nakamura G, Vandlen R, Kelley RF, Wu LC, Eigenbrot C. Structural basis of signaling blockade by anti-IL- 13 antibody Lebrikizumab. J Mol Biol 2013;425: 1330-1339.
46. Scheerens H, Arron JR, Zheng Y, Putnam WS, Erickson RW, Choy DF, Harris JM, Lee J, Jarjour NN, Matthews JG. The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge. Clin Exp Allergy 2014;44: 38-46.
47. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011;365: 1088-1098.
48. Hanania NA, Noonan M, Corren J, Korenblat P, Zheng Y, Fischer SK, Cheu M, Putnam WS, Murray E, Scheerens H, et al. Lebrikizumab in moderate-to-severe asthma: Pooled data from two randomised placebo-controlled studies. Thorax 2015;70: 748-756.
49. Noonan M, Korenblat P, Mosesova S, Scheerens H, Arron JR, Zheng Y, Putnam WS, Parsey MV, Bohen SP, Matthews JG. Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids. J Allergy Clin Immunol 2013;132: 567-574.e12.
50. Brightling CE, Chanez P, Leigh R, O'Byrne PM, Korn S, She D, May RD, Streicher K, Ranade K, Piper E. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: A randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med 2015;3: 692-701.
51. Hanania NA, Wenzel S, Rosén K, Hsieh HJ, Mosesova S, Choy DF, Lal P, Arron JR, Harris JM, Busse W. Exploring the effects of omalizumab in allergic asthma: An analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med 2013;187: 804-811.
52. Kanemitsu Y, Matsumoto H, Izuhara K, Tohda Y, Kita H, Horiguchi T, Kuwabara K, Tomii K, Otsuka K, Fujimura M, et al. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol 2013;132: 305-12.e3.
53. Nagasaki T, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Kita H, Horiguchi T, Kuwabara K, Tomii K, Otsuka K, et al Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes. J Allergy Clin Immunol 2014;133: 1474-1477.
54. Nagasaki T, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Horiguchi T, Kita H, Tomii K, Fujimura M, Yokoyama A, et al. Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma. Am J Respir Crit Care Med 2014; 190: 1449-1452.
55. Laitinen A, Altraja A, Kämpe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997;156: 951-958.
56. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1: 520-524.
57. Arima K, Ohta S, Takagi A, Shiraishi H, Masuoka M, Ontsuka K, Suto H, Suzuki S, Yamamoto K, Ogawa M, et al. Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis. Allergol Int 2015;64: 41-48.
58. Kou K, Okawa T, Yamaguchi Y, Ono J, Inoue Y, Kohno M, Matsukura S, Kambara T, Ohta S, Izuhara K, et al. Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis. Br J Dermatol 2014;171: 283-291.
59. Ohta N, Kurakami K, Ishida A, Furukawa T, Saito F, Kakehata S, Izuhara K. Clinical and pathological characteristics of IgG4-related sclerosing sialadenitis. Laryngoscope 2012;122: 572-577.
60. Nishizawa H, Matsubara A, Nakagawa T, Ohta N, Izuhara K, Shirasaki T, Abe T, Takeda I, Shinkawa H. The role of periostin in eosinophilic otitis media. Acta Otolaryngol 2012;132: 838-844.
61. Yamaguchi Y, Ono J,Masuoka M, Ohta S, Izuhara K, Ikezawa Z, Aihara M, Takahashi K. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br J Dermatol 2013;168: 717-725.
62. Yoshida S, Ishikawa K, Asato R, Arima M, Sassa Y, Yoshida A, Yoshikawa H, Narukawa K, Obika S, Ono J, et al. Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2011;52: 5670-5678.
63. Oku E, Kanaji T, Takata Y, Oshima K, Seki R, Morishige S, Imamura R, Ohtsubo K, Hashiguchi M, Osaki K, et al. Periostin and bone marrow fibrosis. Int J Hematol 2008;88: 57-63.
64. Mikheev AM, Mikheeva SA, Trister AD, Tokita MJ, Emerson SN, Parada CA, Born DE, Carnemolla B, Frankel S, Kim DH, et al. Periostin is a novel therapeutic target that predicts and regulates glioma malignancy. Neuro-oncol 2015;17: 372-382.
65. Orecchia P, Conte R, Balza E, Castellani P, Borsi L, Zardi L, Mingari MC, Carnemolla B. Identification of a novel cell binding site of periostin involved in tumour growth. Eur J Cancer 2011;47: 2221-2229.
66. Hixson JE, Shimmin LC, Montasser ME, Kim DK, Zhong Y, Ibarguen H, Follis J, Malcom G, Strong J, Howard T, et al. Common variants in the periostin gene influence development of atherosclerosis in young persons. Arterioscler Thromb Vasc Biol 2011;31: 1661-1667.
67. Zhu JZ, Zhu HT, Dai YN, Li CX, Fang ZY, Zhao DJ, Wan XY, Wang YM, Wang F, Yu CH, et al. Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: A case-control study. Endocrine 2016;51: 91-1.
68. Sasaki H, Roberts J, Lykins D, Fujii Y, Auclair D, Chen LB. Novel chemiluminescence assay for serum periostin levels in women with preeclampsia and in normotensive pregnant women. Am J Obstet Gynecol 2002;186: 103-108.
69. Wantanasiri P, Satirapoj B, Charoenpitakchai M, Aramwit P. Periostin: A novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients. Lupus 2015;24: 835-845.